Search results
Results from the WOW.Com Content Network
There is also evidence that the probiotic yeast Saccharomyces boulardii, [79] and the plant Mallotus oppositifolius [86] may be effective against Blastocystis infections. Physicians have described the successful use of a variety of discontinued antiprotozoals in treatment of Blastocystis infection.
Blastocystis hominis is a single-celled eukaryotic organism that inhabits the gastrointestinal tract of humans and various animals. [1] This stramenopile exhibits significant genetic diversity and has become an organism of increasing scientific interest due to its widespread distribution and controversial role in human health. [ 2 ]
Blastocystis has low host specificity, and many different species of Blastocystis can infect humans, [3] and by current convention, any of these species would be identified as Blastocystis hominis. Blastocystis is one of the most common human parasites in the world and has a global distribution.
[135] [143] [144] Successful treatment of life-threatening infections with intravenous phage therapy has been documented. [145] Patients have responded to therapy after one or several intravenous administrations, clearing infections that were unresponsive to conventional treatments: [ 135 ] [ 146 ] phages can disrupt biofilms , which are often ...
Ketoconazole was the azole drug first used for blastomycosis treatment, but has been largely replaced by itraconazole because ketoconazole is less effective and less tolerated by patients. [10] The azole treatment generally lasts for a minimum of six months. Cure rates from itraconazole treatment are nearly 95%. [10]
Treatment Metronidazole for the invasive trophozoites PLUS a lumenal amoebicide for those still in the intestine. Paromomycin (Humatin) is the luminal drug of choice, since Diloxanide furoate (Furamide) is not commercially available in the United States or Canada (being available only from the Centers for Disease Control and Prevention).
White explained in an email that his reaction to Hazelden’s plan was “one of pleasant surprise that a leading addiction treatment program would so value the emerging addiction science and be so committed to improving recovery outcomes that it would be willing to weather potential controversy that could affect its business interests.”
Entamoeba coli is a non-pathogenic species of Entamoeba that frequently exists as a commensal parasite in the human gastrointestinal tract. E. coli (not to be confused with the bacterium Escherichia coli) is important in medicine because it can be confused during microscopic examination of stained stool specimens with the pathogenic Entamoeba histolytica. [1]